Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Tretinoin
Drug ID BADD_D02270
Description Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).
Indications and Usage For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.
Marketing Status Prescription; Discontinued
ATC Code D10AD01; L01XF01
DrugBank ID DB00755
KEGG ID D00094
MeSH ID D014212
PubChem ID 444795
TTD Drug ID D02DGU
NDC Product Code 0378-8093; 48943-0011; 0378-8090; 17337-0045; 0378-6140; 62032-417; 79572-030; 10370-268; 53002-8100; 62032-413; 0187-5162; 0378-8082; 68634-069; 0574-2201; 13548-070; 63629-8752; 0574-2205; 16714-249; 62032-414; 68682-513; 0187-5170; 50090-0651; 0378-8084; 0187-0005; 51672-1394; 63629-2285; 51927-1270; 0378-8083; 62032-412; 70518-3233; 55361-0028; 0187-5150; 64566-0009; 70518-3223; 68682-514; 0574-2301; 49452-6243; 16714-250; 0187-5146; 0187-5140; 0574-2225; 42291-870; 50090-3058; 0187-5160; 0187-5172; 53002-8101; 71052-401; 0378-8092; 68462-792; 0187-5164; 51552-0120; 38779-0001; 62049-003; 0555-0808; 17337-0036; 0904-6867; 0378-6141; 0378-8086; 68084-075; 62991-2057; 0187-5148; 51672-1395; 50090-4347; 76055-0007; 50090-3128; 42291-843; 0187-5144; 50090-4486; 0472-0117; 0378-8085; 0574-2325; 68682-800; 76420-159
Synonyms Tretinoin | Retinoic Acid | Acid, Retinoic | Vitamin A Acid | Acid, Vitamin A | all-trans-Retinoic Acid | Acid, all-trans-Retinoic | all trans Retinoic Acid | trans-Retinoic Acid | Acid, trans-Retinoic | trans Retinoic Acid | Retin-A | Retin A | Tretinoin Potassium Salt | Potassium Salt, Tretinoin | Salt, Tretinoin Potassium | Tretinoin Zinc Salt | Salt, Tretinoin Zinc | Zinc Salt, Tretinoin | Vesanoid | beta-all-trans-Retinoic Acid | Acid, beta-all-trans-Retinoic | beta all trans Retinoic Acid | Tretinoin Sodium Salt | Salt, Tretinoin Sodium | Sodium Salt, Tretinoin
Chemical Information
Molecular Formula C20H28O2
CAS Registry Number 302-79-4
SMILES CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Confusional state19.13.01.001; 17.02.03.005--
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Cough22.02.03.001--
Crohn's disease07.08.01.015; 10.02.01.0050.001300%Not Available
Cushingoid14.11.01.006; 05.01.01.002; 24.08.02.004; 19.07.03.001--
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.002--
Cystitis20.03.02.002; 11.01.14.001--
Deafness04.02.01.001--Not Available
Death08.04.01.001--
Dehydration14.05.05.001--
Delirium19.13.02.0010.000520%
Dementia19.20.02.001; 17.03.01.001--Not Available
Depressed level of consciousness17.02.04.002--
Depression19.15.01.0010.002601%
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis allergic23.03.04.003; 10.01.03.014--Not Available
Dermatitis atopic23.03.04.016; 10.01.04.004--Not Available
Dermatitis bullous23.03.01.002--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Disseminated intravascular coagulation24.01.01.010; 01.01.02.0020.000339%
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dry mouth07.06.01.002--
Dry skin23.03.03.0010.002341%
Duodenal ulcer07.04.02.002--
Dysarthria19.19.03.001; 17.02.08.001--
Dyspepsia07.01.02.001--
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 11 Pages